•
Sep 30, 2024

Solid Biosciences Q3 2024 Earnings Report

EPS
-$0.79
Previous year: -$1.05
-24.8%
Gross Profit
$0
Previous year: -$588K
-100.0%
Cash and Equivalents
$171M
Previous year: $143M
+19.8%
Free Cash Flow
-$23.7M
Previous year: -$18.3M
+29.8%
Total Assets
$212M
Previous year: $185M
+14.7%

Solid Biosciences

Solid Biosciences